Pathstone Holdings’s CollPlant Biotechnologies OPHI Stock Holding History

Pathstone Holdings’s Portfolio OPHI Stock Details OPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5,700	Closed	-$19.9K	–	2405
2026 Q2	$19.9K	Hold	5,700	–	–	﹤0.01%	2326
2026 Q1	$30.6K	Buy	5,700 +4,000	+235%	+$40.4K	﹤0.01%	2200
2025 Q4	$23.8K	Hold	1,700	–	–	﹤0.01%	2208
2025 Q3	$45.7K	Sell	1,700 -1,700	-50%	-$40.5K	﹤0.01%	2310
2025 Q2	$23.1K	Buy	3,400 +1,700	+100%	+$35.2K	﹤0.01%	2166
2025 Q1	$43.9K	Hold	1,700	–	–	﹤0.01%	2182
2024 Q4	$61.2K	Hold	1,700	–	–	﹤0.01%	2256
2024 Q3	$84.4K	Buy	+1,700	New	+$83.2K	﹤0.01%	2252

Other funds holding OPHI

St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Strive Financial Group Carmel, Indiana $316M AUM 17.91% 1-Year Est. Return

Pathstone Holdings's OPHI Position: Q3 2026 in Review

Pathstone Holdings sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 5,700 shares — an estimated $19.9K sold.

Pathstone Holdings first reported a position in OPHI in Q3 2024 and held it in 8 quarters. The position peaked at $84.4K in Q3 2024. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

Pathstone Holdings reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
Pathstone Holdings sold 5,700 CollPlant Biotechnologies shares in Q3 2026, an estimated $19.9K.
Pathstone Holdings first reported a position in CollPlant Biotechnologies in Q3 2024 and held it in 8 quarters.
Pathstone Holdings's CollPlant Biotechnologies position peaked at $84.4K in Q3 2024.
7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.